Alternatives to BenevolentAI

Generative AI drug discovery platform spanning target ID to clinical trials, with its own Phase III pipeline as proof.

AI drug discovery engine pairing 2M weekly wet-lab experiments with a 50+ petabyte phenomics dataset

Tech-driven drug discovery and biologics manufacturing platform

All-in-human AI foundation models for precision neurology and CNS drug discovery

Generative AI and robotics platform compressing drug discovery to under two years.

Physics-based molecular discovery platform for drug and materials design

AI-native drug discovery platform turning 50PB+ cellular imaging into clinical-stage therapies

AI-driven drug discovery platform with 50+PB proprietary data and automated wet labs

AI co-scientist for biomedical research: multi-omics, drug discovery, and lab protocol reasoning

AI-driven CRISPR platform revealing causal disease-driving RNA pathways for immunology and oncology drug discovery

AI target discovery for neurotherapeutics targeting neural circuits across disorders

Open-source AI research assistant for accelerated drug discovery, self-hosted with full data control

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Cloud ELN, LIMS, and AI platform that unifies biotech R&D data for discovery teams.

FDA-cleared AI for cancer pathology diagnostics and biomarker discovery.

Causal AI for human health, turning 20+ petabytes of cellular data into targeted therapeutics.

PathAI is an enterprise AI pathology platform for diagnostic accuracy and biopharma drug development.

Evidence-based AI research assistant with connected knowledge maps for life sciences.

AI foundation models predicting patient drug response to de-risk clinical trials

AI-designed multivalent nanoparticles for cell-selective drug delivery

Owkin's K Pro: an autonomous AI scientist for biopharma R&D decision-making

Silico: mechanistic interpretability platform to understand, debug, and design AI models

Oncology real-world evidence platform that turns patient data into AI-powered cancer research insights.

AI-driven clinical trial patient matching and recruitment from EMR data.

Quibim turns MRI, CT, and PET scans into regulatory-cleared quantitative imaging biomarkers for radiology and biopharma

AI-powered precision oncology platform analyzing clinical and molecular data for personalized cancer care.

ML-guided protein engineering platform to co-optimize multiple properties with your own experimental data

AI cell therapy manufacturing with laser precision and closed-loop control

Causal AI drug discovery models that predict how biology responds to perturbation, from target to patient.

Dotmatics Luma Agent: agentic AI for multimodal R&D data analysis and scientific workflow automation